September 15, 2025

Chronic Insomnia Accelerates Cognitive Decline

Mayo Clinic study links chronic insomnia to 40% higher risk of cognitive impairment in older adults

Conexiant

September 15, 2025

Pilot study tests ALS drug to treat chemo brain in cancer patients

A first-of-its-kind study tests ALS drug riluzole to restore cognitive function in cancer survivors.

UCI Health

September 15, 2025

Nanoneedles Unlock Lipid Profiling in Live Brain Tissue

New workflow is developed for spatiotemporal lipidomics to classify gliomas and monitor treatment response

The Pathologist

September 12, 2025

AI-Powered Proteomics Sharpens ALS Diagnosis

Researchers identified a biomarker panel predicting amyotrophic lateral sclerosis onset

The Pathologist

September 11, 2025

"Magic Mushroom" Edibles Lack Psilocybin

Analysis of retail products reveals widespread adulteration with synthetic compounds, posing unknown health risks.

Conexiant

September 10, 2025

Prenatal Acetaminophen and ADHD/ASD: Linked?

Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.

Conexiant

September 10, 2025

What Role Do Omega-3s Play in Dementia Prevention?

Observational evidence suggests omega-3s may help shield aging brains, though randomized trials remain mixed.

Conexiant

September 09, 2025

Six-Minute Walk Test Flags Risk in ATTR-CM

In a single‑center registry, baseline and 1‑year distances below 350 meters identified higher‑risk patients with transthyretin amyloid cardiomyopathy; changes in distance were prognostic mainly with stable therapy.

Conexiant

September 09, 2025

Glipizide Linked to 13% Higher Heart Risk

Sulfonylurea choice after metformin affects long-term cardiovascular event likelihood.

Conexiant